Viewing StudyNCT00511095



Ignite Creation Date: 2024-05-05 @ 6:38 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00511095
Status: COMPLETED
Last Update Posted: 2019-04-30
First Post: 2007-07-25

Brief Title: Open-Label Study of the Safety and Immunogenicity of HEPLISAV Hepatitis B Virus Vaccine
Sponsor: Dynavax Technologies Corporation
Organization: Dynavax Technologies Corporation

Conditions & Keywords Data

Conditions:
Name
Hepatitis B
Keywords:
Name View
HBsAg View
Hepatitis B vaccine View
HBV vaccine View
Hepatitis B View
Hepatitis View
HBV View
Vaccine View
1018 View